Kohli Divyanshoo R, Kennedy Kevin F, Desai Madhav, Sharma Prateek
Division of Gastroenterology and Hepatology, Kansas City VA Medical Center, Missouri, USA.
St. Luke's Medical Center, Kansas City, Missouri, USA.
Am J Gastroenterol. 2021 Dec 1;116(12):2367-2373. doi: 10.14309/ajg.0000000000001504.
A gastrostomy is generally performed in patients who are unable to maintain volitional intake of food. We compared outcomes of percutaneous endoscopic gastrostomy (PEG) and interventional radiologist-guided gastrostomy (IRG) using an integrated nationwide database.
Using the VA Informatics and Computing Infrastructure database, patients who underwent PEG or IRG from 2011 through 2021 were selected using Current Procedural Terminology and International Classification of Diseases codes. The primary outcome was the comparative incidence of adverse events between PEG and IRG. Secondary outcomes included all-cause mortality. Comorbidities were identified using International Classification of Diseases codes, and adjusted odds ratio (OR) for adverse events were calculated using multivariate logistic regression analysis.
A total of 23,566 (70.7 ± 10.2 years) patients underwent PEG and 9,715 (69.6 ± 9.7 years) underwent IRG. Selected frequent indications for PEG vs IRG were as follows: stroke, 6.8% vs 5.3%, P < 0.01; aspiration pneumonia, 10.9% vs 6.8%, P < 0.001; feeding difficulties, 9.8% vs 6.3%, P < 0.01; and upper aerodigestive tract malignancies 58.8% vs 79.8%, P < 0.01. Across all subtypes of malignancies of the head and neck and foregut, the proportion of patients undergoing IRG was greater than those undergoing PEG (P < 0.001). The all-cause 30-day mortality and overall incidence of adverse events were significantly lower for PEG compared with those for IRG (PEG vs IRG): all-cause 30-day mortality, 9.35% vs 10.3% (OR 0.80; 95% confidence interval [CI] 0.74-0.87; P < 0.01); perforation of the colon, 0.12% vs 0.24% (OR 0.50; 95% CI 0.29-0.86; P = 0.04); peritonitis, 1.9% vs 2.7% (OR 0.68; 95% CI 0.58-0.79; P < 0.01); and hemorrhage 1.6% vs 1% (OR 1.47; 95% CI 1.18-1.83; P < 0.01).
In a large nationwide database of more than 33,000 gastrostomy procedures, PEG was associated with a lower incidence of adverse outcomes and the 30-day mortality than IRG.
胃造口术通常用于无法自主摄入食物的患者。我们使用一个全国性综合数据库比较了经皮内镜下胃造口术(PEG)和介入放射科医生引导下胃造口术(IRG)的结果。
利用退伍军人事务部信息学和计算基础设施数据库,通过当前手术操作术语和国际疾病分类代码选择2011年至2021年期间接受PEG或IRG的患者。主要结局是PEG和IRG之间不良事件的比较发生率。次要结局包括全因死亡率。使用国际疾病分类代码确定合并症,并使用多变量逻辑回归分析计算不良事件的调整优势比(OR)。
共有23566名(70.7±10.2岁)患者接受了PEG,9715名(69.6±9.7岁)患者接受了IRG。PEG与IRG常见的选定适应证如下:中风,6.8%对5.3%,P<0.01;吸入性肺炎,10.9%对6.8%,P<0.001;喂养困难,9.8%对6.3%,P<0.01;上消化道恶性肿瘤,58.8%对79.8%,P<0.01。在头颈部和前肠所有恶性肿瘤亚型中,接受IRG的患者比例高于接受PEG的患者(P<0.001)。与IRG相比,PEG的全因30天死亡率和不良事件总发生率显著更低(PEG与IRG):全因30天死亡率,9.35%对10.3%(OR 0.80;95%置信区间[CI]0.74 - 0.87;P<0.01);结肠穿孔,0.12%对0.24%(OR 0.50;95%CI 0.29 - 0.86;P = 0.04);腹膜炎,1.9%对2.7%(OR 0.68;95%CI 0.58 - 0.79;P<0.01);出血,1.6%对1%(OR 1.47;95%CI 1.18 - 1.83;P<0.01)。
在一个超过33000例胃造口术的大型全国性数据库中,与IRG相比,PEG的不良结局发生率和30天死亡率更低。